Roxana Mehran Selected Research

Thrombocytopenia (Thrombopenia)

11/2021	Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
1/2020	Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
2/2016	Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention.
1/2015	Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.
4/2014	Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).
2/2011	Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
2/2011	Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
8/2005	Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roxana Mehran Research Topics

Disease

368	Myocardial Infarction 12/2022 - 01/2002
289	Hemorrhage 12/2022 - 02/2004
275	Thrombosis (Thrombus) 12/2022 - 01/2002
161	ST Elevation Myocardial Infarction 01/2022 - 03/2005
157	Acute Coronary Syndrome 11/2022 - 10/2003
134	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 05/2002
84	Stroke (Strokes) 11/2022 - 09/2003
79	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 04/2004
62	Death (Near-Death Experience) 01/2022 - 02/2004
57	Diabetes Mellitus 09/2022 - 01/2002
49	Atrial Fibrillation 10/2022 - 01/2003
45	Ischemia 01/2022 - 01/2003
37	Infarction (Infarctions) 01/2021 - 09/2003
30	Chronic Renal Insufficiency 09/2022 - 08/2004
28	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 10/2009
25	Heart Failure 11/2022 - 10/2011
23	Anemia 10/2022 - 08/2004
23	Pathologic Constriction (Stenosis) 10/2015 - 06/2001
18	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 01/2011
16	Hyperplasia 07/2022 - 05/2002
16	AIDS-Related Complex (ARC) 12/2021 - 08/2005
14	Coronary Disease (Coronary Heart Disease) 10/2022 - 04/2004
13	Hypertension (High Blood Pressure) 11/2022 - 01/2006
12	Atherosclerosis 01/2022 - 04/2004
11	Inflammation (Inflammations) 10/2022 - 03/2005
11	Peripheral Arterial Disease 01/2022 - 02/2004
11	Unstable Angina 01/2022 - 04/2005
11	Renal Insufficiency (Renal Failure) 01/2020 - 12/2003
9	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 08/2005
9	Atherosclerotic Plaque (Atheroma) 01/2021 - 11/2004
9	Non-ST Elevated Myocardial Infarction 12/2019 - 08/2006
8	Thrombocytopenia (Thrombopenia) 11/2021 - 08/2005
8	Coronary Stenosis (Coronary Artery Stenosis) 01/2019 - 06/2001
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2002
6	Hematoma 06/2010 - 02/2004
5	Ischemic Stroke 01/2022 - 03/2015
5	Left Ventricular Dysfunction 11/2020 - 03/2002
5	Stable Angina 08/2019 - 10/2007
4	Hypotension (Low Blood Pressure) 11/2022 - 08/2004

Drug/Important Bio-Agent (IBA)

116	omega-Chloroacetophenone (Mace)IBA 03/2022 - 05/2002
102	bivalirudin (Angiomax)FDA Link 11/2021 - 09/2005
88	Heparin (Liquaemin)FDA LinkGeneric 11/2021 - 09/2003
65	Glycoproteins (Glycoprotein)IBA 02/2020 - 10/2003
63	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 10/2011
51	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2022 - 10/2004
44	Clopidogrel (Plavix)FDA Link 03/2022 - 11/2006
38	MetalsIBA 07/2022 - 03/2005
36	AnticoagulantsIBA 01/2022 - 09/2005
35	Abciximab (ReoPro)FDA Link 10/2016 - 09/2003
29	TicagrelorIBA 09/2022 - 11/2010
29	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 03/2005
27	Vitamin K FDA Link 01/2022 - 03/2012
20	Insulin (Novolin)FDA Link 01/2020 - 04/2004
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
18	Prasugrel Hydrochloride FDA Link 03/2022 - 11/2010
17	Pharmaceutical PreparationsIBA 01/2022 - 10/2007
16	Hemoglobins (Hemoglobin)IBA 11/2021 - 02/2009
16	CreatinineIBA 01/2021 - 01/2002
12	RivaroxabanIBA 01/2022 - 04/2015
12	Sirolimus (Rapamycin)FDA Link 01/2021 - 11/2004
11	apixabanIBA 01/2022 - 01/2018
11	AntithrombinsIBA 11/2015 - 03/2007
10	Everolimus FDA Link 11/2021 - 06/2006
10	Platelet Membrane Glycoprotein IIbIBA 02/2016 - 08/2005
9	PolymersIBA 01/2022 - 04/2005
9	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 05/2011
9	LipidsIBA 12/2020 - 07/2013
8	C-Reactive ProteinIBA 01/2022 - 02/2011
8	TroponinIBA 01/2021 - 04/2012
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 08/2005
7	CholesterolIBA 01/2021 - 10/2016
7	CalciumIBA 01/2018 - 08/2005
7	Phenobarbital (Luminal)FDA Link 04/2016 - 01/2004
7	Enoxaparin (Lovenox)FDA LinkGeneric 10/2012 - 11/2006
6	zotarolimusIBA 01/2022 - 01/2017
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 07/2008
6	Contrast MediaIBA 07/2020 - 01/2005
6	thienopyridineIBA 06/2020 - 02/2009
6	MB Form Creatine KinaseIBA 01/2020 - 03/2002
5	CobaltIBA 01/2021 - 04/2008
5	ChromiumIBA 01/2021 - 04/2008
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021 - 12/2009
5	CSL112IBA 01/2021 - 10/2016
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 10/2016
5	RB 006IBA 12/2016 - 10/2011
4	Biological ProductsIBA 12/2022 - 09/2004

Therapy/Procedure

419	Percutaneous Coronary Intervention 11/2022 - 01/2002
360	Stents 12/2022 - 06/2001
187	Therapeutics 12/2022 - 10/2002
99	Drug-Eluting Stents 10/2022 - 03/2005
58	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 08/2003
33	Transcatheter Aortic Valve Replacement 01/2022 - 01/2011
13	Drug Therapy (Chemotherapy) 01/2021 - 02/2005
12	Patient Readmission 01/2022 - 01/2011
11	Blood Transfusion (Blood Transfusions) 02/2022 - 02/2004
9	Thrombectomy 10/2016 - 02/2007
6	Catheters 01/2022 - 04/2004
6	Vascular Closure Devices 08/2021 - 02/2010
5	Secondary Prevention 01/2021 - 11/2010
5	Thrombolytic Therapy 11/2014 - 04/2004